Sign in

CIK 0002131524 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Braveheart Bio, Inc.

Sign in to watch
Ticker
BRVE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
992981994
Phone
(415) 707-6312
Business address
ONE LETTERMAN DR., BLDG. A, STE. A4-300, SAN FRANCISCO, CA, 94129
  1. 3 Insider Initial Statement of Ownership
  2. 4 Open-market buy 10% owner bought 1,100,000 shares at $18.00 ($19,800,000)
  3. 4 Open-market buy Director bought 1,940,000 shares at $18.00 ($34,920,000)
  4. 4 Open-market buy Director bought 1,940,000 shares at $18.00 ($34,920,000)
  5. 4 Conversion 10% owner acquired 7,420,091 shares (conversion)
  6. 4 Open-market buy 10% owner bought 3,600,000 shares at $18.00 ($64,800,000)
  7. 4 Open-market buy Chief Financial Officer bought 27,777 shares at $18.00 ($499,986)
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Open-market buy Director bought 83,333 shares at $18.00 ($1,499,994)
  11. 4 Open-market buy Director bought 4,166 shares at $18.00 ($74,988)
  12. 4 Open-market buy Chief Development Officer bought 1,111 shares at $18.00 ($19,998)
  13. 4 Open-market buy CEO and President bought 83,333 shares at $18.00 ($1,499,994)
  14. 4 Derivatives Options or other derivatives
  15. 4 Open-market buy Director bought 55,555 shares at $18.00 ($999,990)
  16. 3 Insider Initial Statement of Ownership
  17. 3 Insider Initial Statement of Ownership
  18. 3 Insider Initial Statement of Ownership
  19. 3 Insider Initial Statement of Ownership
  20. 3 Insider Initial Statement of Ownership

Page 1 of 2 · 29 filings